English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The author reflects on a proposal to extend the law informally known as the Physician Payments Sunshine Act (PPSA) to include payments to patient advocacy groups (PAG). She comments on the role of the U.S. Centers for Medicare and Medicaid Services (CMS) in monitoring payments by pharmaceutical companies to physicians and states an expansion of the PPSA would need to be justified based on their effect on CMS drug expenditures. She talks about how PAG could qualify under PPSA disclosure rules.

Extending the Sunshine Act From Physicians to Patient Advocacy Organizations